Literature DB >> 3796631

Anti-complementary action of polymorphic "solubility forms" of particulate inulin.

P D Cooper, M Carter.   

Abstract

Inulin crystallizes in a series of polymorphic forms with different solubility rates, ranging from one instantly soluble at 23 degrees C (beta 0(23) inulin) through a form soluble at 37 degrees C with a half-time of 8 min (alpha 8(37) inulin) to a form virtually insoluble at 37 degrees C (gamma inulin). All forms are interconvertible, the more soluble and unstable progressing on standing to less soluble and more stable forms, only reversible by complete solution followed by recrystallization. The end product is the stable gamma inulin, only formed by polymers greater than 8000 mol. wt. A method is given for preparing pure "gamma inulin for injection", comprising insoluble ovoids of less than 1 micron diameter free of soluble inulin and endotoxin. An assay developed for complement action by the alternative pathway showed that gamma inulin was the most potent activator polymorph, more active than killed S. aureus and zymosan. Dissolved inulin and the more soluble polymorphs were inactive and in a mixture hindered alternative pathway activation by the gamma form.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3796631     DOI: 10.1016/0161-5890(86)90075-1

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  9 in total

1.  The polysaccharide inulin is characterized by an extensive series of periodic isoforms with varying biological actions.

Authors:  Peter D Cooper; Thomas G Barclay; Milena Ginic-Markovic; Nikolai Petrovsky
Journal:  Glycobiology       Date:  2013-07-12       Impact factor: 4.313

2.  Delta inulin: a novel, immunologically active, stable packing structure comprising β-D-[2 -> 1] poly(fructo-furanosyl) α-D-glucose polymers.

Authors:  Peter D Cooper; Nikolai Petrovsky
Journal:  Glycobiology       Date:  2010-12-07       Impact factor: 4.313

Review 3.  Carbohydrate-based immune adjuvants.

Authors:  Nikolai Petrovsky; Peter D Cooper
Journal:  Expert Rev Vaccines       Date:  2011-04       Impact factor: 5.217

4.  Inulin isoforms differ by repeated additions of one crystal unit cell.

Authors:  Peter D Cooper; Thomas G Barclay; Milena Ginic-Markovic; Andrea R Gerson; Nikolai Petrovsky
Journal:  Carbohydr Polym       Date:  2013-12-31       Impact factor: 9.381

5.  Gamma ray sterilization of delta inulin adjuvant particles (Advax™) makes minor, partly reversible structural changes without affecting adjuvant activity.

Authors:  P D Cooper; T G Barclay; M Ginic-Markovic; N Petrovsky
Journal:  Vaccine       Date:  2013-12-14       Impact factor: 3.641

Review 6.  Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases.

Authors:  Akhilesh Kumar Shakya; Kutty Selva Nandakumar
Journal:  J R Soc Interface       Date:  2013-02       Impact factor: 4.118

7.  Randomized controlled trial demonstrating the benefits of delta inulin adjuvanted immunotherapy in patients with bee venom allergy.

Authors:  Robert Heddle; Anthony Smith; Richard Woodman; Pravin Hissaria; Nikolai Petrovsky
Journal:  J Allergy Clin Immunol       Date:  2019-07-09       Impact factor: 10.793

8.  Potentiation of photodynamic therapy of cancer by complement: the effect of gamma-inulin.

Authors:  M Korbelik; P D Cooper
Journal:  Br J Cancer       Date:  2006-12-05       Impact factor: 7.640

9.  Synthesis and Characterization of pH-Sensitive Inulin Conjugate of Isoniazid for Monocyte-Targeted Delivery.

Authors:  Franklin Afinjuomo; Thomas G Barclay; Ankit Parikh; Rosa Chung; Yunmei Song; Gayathri Nagalingam; Jamie Triccas; Lixin Wang; Liang Liu; John D Hayball; Nikolai Petrovsky; Sanjay Garg
Journal:  Pharmaceutics       Date:  2019-10-28       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.